INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
PS

Pieper Steven

See RemarksCIK 0001875714

EDGAR filingsOpen in network
Disclosed transactions10
Buys / sells0 / 5
Max Insider Score19
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
14
PS
Pieper StevenSee Remarks
XERSXeris Biopharma Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$51K
5,000 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Xeris Biopharma Holdings, Inc.See Remarks · Feb 2, 2026
6
PS
Pieper StevenSee Remarks
XERSXeris Biopharma Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL
$43K
5,000 sh
Sep 1, 2026
Sep 1, 2026
traded Sep 1, 2026
+0d
SEC FORM 4

Evidence

1
PS
Pieper StevenSee Remarks
XERSXeris Biopharma Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$43K
5,000 sh
Aug 12, 2026Aug 12, 2026
traded Aug 12, 2026
+0dSEC FORM 4

Evidence

9
PS
Pieper StevenSee Remarks
XERSXeris Biopharma Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$235K
27.6K sh
Jul 7, 2026Jul 7, 2026
traded Jul 7, 2026
+0dSEC FORM 4

Evidence

13
PS
Pieper StevenSee Remarks
XERSXeris Biopharma Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$148K
17.4K sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC FORM 4

Evidence

19
PS
Pieper StevenSee Remarks
XERSXeris Biopharma Holdings, Inc.
Tax withholding
F$489K
66.5K sh
Jan 31, 2026Feb 2, 2026
traded Jan 31, 2026
+2dSEC FORM 4

Evidence

13
PS
Pieper StevenSee Remarks
XERSXeris Biopharma Holdings, Inc.
Grant or award
A—
155.0K sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC FORM 4

Evidence

9
PS
Pieper StevenSee Remarks
XERSXeris Biopharma Holdings, Inc.
Grant or award
A—
207.2K sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC FORM 4

Evidence

12
PS
Pieper StevenSee Remarks
XERSXeris Biopharma Holdings, Inc.
Tax withholding
F$201K
27.3K sh
Jan 31, 2026Feb 2, 2026
traded Jan 31, 2026
+2dSEC FORM 4

Evidence

19
PS
Pieper StevenSee Remarks
XERSXeris Biopharma Holdings, Inc.
Tax withholding
F$823K
111.8K sh
Jan 31, 2026Feb 2, 2026
traded Jan 31, 2026
+2dSEC FORM 4

Evidence